Search Media Items

The role of retail pharmacies/pharmacists in vaccine delivery in the United States by Mr. M Rothholz Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=2483423186d83b355cfdb6f0f247b13d20130730145139031

Update on Herpes Zoster Work Group activities by Dr. J Duchin. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=e1de9489e17439ba7d586ce6a2eac77420130730150613375

Introduction by Dr. M Sawyer. Pertussis in the United States and Tdap vaccine effectiveness by Dr. A Acosta. Tdap revaccination: safety and immunogenicity by Dr. J Liang. Decision and cost effectiveness analysis: a second dose of Tdap by Dr. M. Messonnier, Dr. H Kamiya. Work group conclusions on a second dose of Tdap by Dr. J Liang. Maternal Tdap and cocooning: experiences from Australia and the United Kingdom by Dr. P McIntyre, Dr. D Salisbury. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=8a1f7d5638cd206be3b576b1969e0f0520130730141810953

Introduction: intussusception following RV5 and RV1 by Dr. M Vázquez. VSD by Mr. E Weintraub. VAERS by Ms. P Haber. PRISM by Dr. K Yih. Australian data by Dr. P McIntyre. Summary and review of risk: benefit in the United States by Dr. M Cortese. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=b72d088d3e8589b4eb51e59519a3e70e20130730143433859

Introduction by Dr. J Bocchini. Safety and immunogenicity of JE-VC in children by Dr. K Dubischar-Kastner. GRADE evidence for JE-VC in children, Recommendations for use by Dr. M Fischer. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=4d51af6143d81759701246aa2400c96c20130730140630234

Overview by Dr. J Duchin. Preventing and managing adverse reactions by Dr. A Kroger. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=aa249e5b01a2d08e75b0140d79590ab420130730141126234

Introduction by Dr. J Bocchini. Merck pregnancy registry for quadrivalent HPV vaccine by Dr. F Lievano. Plans for updated ACIP statement by Dr. E Dunne. HPV vaccine program and impact monitoring by Dr. L Markowitz. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=f030e0e083784417044a1b9b75008fc820130730142723328

Opening remarks for June 2013 The U.S. Advisory Committee of Immunization Practices meeting hosted by Dr. Jon Temte and Dr. Larry Pickering. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at: http://streaming.cdc.gov/vod.php?id=6d1740eceeb88604b828ba9580b53bc620130730140231828

2015 Immunization Schedules for children 0 through 18 years of Age, 2015 Adult Immunization Schedule, Introduction Hepatitis A, Update on Hepatitis A Disease Burden and population protection. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://ftp.cdc.gov/pub/vaccines/acip/Oct2014/Child-Adult-Hepatitus-Adjourn.mp4

Introduction, 9-valent HPV vaccine program key results. Increment cost-effectiveness of the 9-valent vs 4-valent HPV vaccine, GRADE for 9-valent HPV vaccine, overview of issues and considerations Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://ftp.cdc.gov/pub/vaccines/acip/Oct2014/HPV-Adjourn.mp4